Navigation
Navigation
User login

Albania  |  Armenia  |  Austria  |  Azerbaijan  |  Belarus  |  Belgium  |  Bosnia and Herzegovina  |  Bulgaria  |  Croatia  |  Cyprus  |  Czech Republic  |  Denmark  |  Estonia  |  Finland  |  France  |  Georgia  |  Germany  |  Greece  |  Hungary  |  Iceland  |  Ireland  |  Israel  |  Italy  |  Kazakhstan  |  Kosovo  |  Latvia  |  Lithuania  |  Luxembourg  |  Malta  |  Moldova  |  Monaco  |  Montenegro  |  Norway  |  Poland  |  Portugal  |  Romania  |  Russia  |  Serbia  |  Slovakia  |  Slovenia  |  Spain  |  Sweden  |  Switzerland  |  The former Yugoslav Republic of Macedonia  |  The Netherlands  |  Turkey  |  Ukraine  |  United Kingdom

Albania

There are no national guidelines currently listed for this country.

Armenia

There are no national guidelines currently listed for this country.

Austria

There are no national guidelines currently listed for this country.

Azerbaijan

There are no national guidelines currently listed for this country.

Belarus

There are no national guidelines currently listed for this country.

Belgium

There are no national guidelines currently listed for this country.

Bosnia and Herzegovina

There are no national guidelines currently listed for this country.

Bulgaria

There are no national guidelines currently listed for this country.

Croatia

There are no national guidelines currently listed for this country.

Cyprus

There are no national guidelines currently listed for this country.

Czech Republic

There are no national guidelines currently listed for this country.

Denmark

Guidelines to Patient Management of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia - Nordic MDS Group - 8th update May 2017.

Estonia

There are no national guidelines currently listed for this country.

Finland

Guidelines to Patient Management of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia - Nordic MDS Group - 8th update May 2017.

France

CONSENSUS FRANÇAIS SUR LES SYNDROMES MYELODYSPLASIQUES (SMD) ET LA LEUCÉMIE MYÉLOMONOCYTAIRE CHRONIQUE: DIAGNOSTIC, CLASSIFICATIONS, TRAITEMENT. Fenaux P, Ades L, Fontenay M, Raynaud S, Eclache V, Rose C, Guerci- Bressler A, Gyan E, Bardet V, Robin M, Prebet T, Itzykson R, Cluzeau T, Amé-Natarajan S, Stamatoullas A, Wattel E, Park S, Beyne Rauzy O, Isnard F, Quesnel B, Yacoub Agha I, Toma A, Tavares S, Braun T, Gardin C, Chèze S, Delaunay J, Dimicoli S, Kosmider O, Renneville A, Preudhomme C, Cresty N, Vey N, Dreyfus F. (Mise à jour 2015).

French Consensus on Myelodysplastic Syndromes (MDS), and chronic Myelomonocytic leukemia: diagnosis, classification and treatment. Fenaux P, Ades L, Fontenay M, Raynaud S, Eclache V, Rose C, Guerci- Bressler A, Gyan E, Bardet V, Robin M, Prebet T, Itzykson R, Cluzeau T, Amé-Natarajan S, Stamatoullas A, Wattel E, Park S, Beyne Rauzy O, Isnard F, Quesnel B, Yacoub Agha I, Toma A, Tavares S, Braun T, Gardin C, Chèze S, Delaunay J, Dimicoli S, Kosmider O, Renneville A, Preudhomme C, Cresty N, Vey N, Dreyfus F. (2015 update).

Other national MDS-related recommendations:

Georgia

There are no national guidelines currently listed for this country.

Greece

There are no national guidelines currently listed for this country.

Hungary

There are no national guidelines currently listed for this country.

Iceland

Guidelines to Patient Management of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia - Nordic MDS Group - 8th update May 2017.

Ireland

There are no national guidelines currently listed for this country.

Israel

There are no national guidelines currently listed for this country.

Italy

There are no national guidelines currently listed for this country.

Kazakhstan

There are no national guidelines currently listed for this country.

Kosovo

There are no national guidelines currently listed for this country.

Latvia

There are no national guidelines currently listed for this country.

Lithuania

There are no national guidelines currently listed for this country.

Luxembourg

There are no national guidelines currently listed for this country.

Malta

There are no national guidelines currently listed for this country.

Moldova

There are no national guidelines currently listed for this country.

Monaco

There are no national guidelines currently listed for this country.

Montenegro

There are no national guidelines currently listed for this country.

Norway

Guidelines to Patient Management of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia - Nordic MDS Group - 8th update May 2017.

Poland

There are no national guidelines currently listed for this country.

Portugal

There are no national guidelines currently listed for this country.

Romania

There are no national guidelines currently listed for this country.

Russia

There are no national guidelines currently listed for this country.

Serbia

There are no national guidelines currently listed for this country.

Slovakia

There are no national guidelines currently listed for this country.

Slovenia

There are no national guidelines currently listed for this country.

Spain

Guías Españolas para el Diagnóstico y Tratamiento de los SMD y la LMMC. Grupo Español de Síndromes Mielodisplásicos (GESMD). 2013.

Sweden

Guidelines to Patient Management of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia - Nordic MDS Group - 8th update May 2017.

Switzerland

There are no national guidelines currently listed for this country.

The former Yugoslav Republic of Macedonia

There are no national guidelines currently listed for this country.

The Netherlands

There are no national guidelines currently listed for this country.

Turkey

There are no national guidelines currently listed for this country.

Ukraine

There are no national guidelines currently listed for this country.

United Kingdom

Guidelines for the diagnosis and management of adult myelodysplastic syndromes published by the British Committee for Standards in Haematology (BCSH)